{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T15:30:42Z","timestamp":1781191842577,"version":"3.54.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":433,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006313","name":"Swedish Childhood Cancer Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006313","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001862","name":"The Swedish Research Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001862","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003748","name":"Swedish Society for Medical Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003748","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004348","name":"Stockholm County Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.bbmt.2013.11.011","type":"journal-article","created":{"date-parts":[[2013,11,22]],"date-time":"2013-11-22T11:32:08Z","timestamp":1385119928000},"page":"264-271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Analysis of Donor and Recipient ABO Incompatibility and Antibody-Associated Complications after Allogeneic Stem Cell Transplantation with Reduced-Intensity Conditioning"],"prefix":"10.1016","volume":"20","author":[{"given":"Emma","family":"Watz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats","family":"Remberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olle","family":"Ringden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Lundahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Ljungman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Mattsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agneta","family":"Wikman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Uhlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2013.11.011_bib1","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1365-2141.2009.07886.x","article-title":"The allogeneic graft-versus-cancer effect","volume":"147","author":"Ringden","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2013.11.011_bib2","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1423-0410.2009.01292.x","article-title":"Transfusion policy in ABO-incompatible allogeneic stem cell transplantation","volume":"98","author":"Worel","year":"2010","journal-title":"Vox Sang"},{"key":"10.1016\/j.bbmt.2013.11.011_bib3","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1016\/S0041-1345(03)00766-8","article-title":"Factors that impact on immediate graft function in patients after renal transplantation","volume":"35","author":"Sienko","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1016\/j.bbmt.2013.11.011_bib4","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/00007890-197810000-00006","article-title":"ABO-incompatible marrow transplants","volume":"26","author":"Buckner","year":"1978","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2013.11.011_bib5","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1182\/blood.V60.2.420.420","article-title":"Bone marrow transplantation with major ABO blood group incompatibility using erythrocyte depletion of marrow prior to infusion","volume":"60","author":"Braine","year":"1982","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.11.011_bib6","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1046\/j.1537-2995.1983.23483276858.x","article-title":"Hemotherapy in patients undergoing blood group incompatible bone marrow transplantation","volume":"23","author":"Lasky","year":"1983","journal-title":"Transfusion"},{"key":"10.1016\/j.bbmt.2013.11.011_bib7","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/00007890-198204000-00017","article-title":"ABO-incompatible marrow transplants","volume":"33","author":"Bensinger","year":"1982","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2013.11.011_bib8","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.bbmt.2005.07.015","article-title":"ABO blood group barrier in allogeneic bone marrow transplantation revisited","volume":"11","author":"Seebach","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.11.011_bib9","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.bbmt.2007.01.084","article-title":"Major ABO blood group mismatch increases the risk for graft failure after unrelated donor hematopoietic stem cell transplantation","volume":"13","author":"Remberger","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.11.011_bib10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/sj.bmt.1703621","article-title":"Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantation","volume":"30","author":"Stussi","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.11.011_bib11","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0145-2126(02)00259-X","article-title":"ABO incompatibility between donor and recipient and clinical outcomes in allogeneic stem cell transplantation","volume":"27","author":"Goldman","year":"2003","journal-title":"Leuk Res"},{"key":"10.1016\/j.bbmt.2013.11.011_bib12","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/bmt.2010.218","article-title":"Delayed platelet recovery after allogeneic transplantation: a predictor of increased treatment-related mortality and poorer survival","volume":"46","author":"Ramirez","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.11.011_bib13","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1089\/scd.2011.0310","article-title":"Mesenchymal stem cells inhibit thymic reconstitution after allogeneic cord blood transplantation","volume":"21","author":"Uhlin","year":"2012","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.bbmt.2013.11.011_bib14","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1046\/j.1537-2995.2003.00465.x","article-title":"ABO mismatch increases transplant-related morbidity and mortality in patients given nonmyeloablative allogeneic HPC transplantation","volume":"43","author":"Worel","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.bbmt.2013.11.011_bib15","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/bmt.2009.82","article-title":"Allogeneic hematopoietic SCT in patients with non-malignant diseases, and importance of chimerism","volume":"44","author":"Svenberg","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.11.011_bib16","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.bbmt.2013.02.015","article-title":"Chimerism patterns of long-term stable mixed chimeras post hematopoietic stem cell transplantation in patients with nonmalignant diseases: follow-up of long-term stable mixed chimerism patients","volume":"19","author":"Stikvoort","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.11.011_bib17","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.1365-2141.2005.05364.x","article-title":"Persistence of recipient plasma cells and anti-donor isohaemagglutinins in patients with delayed donor erythropoiesis after major ABO incompatible non-myeloablative haematopoietic cell transplantation","volume":"128","author":"Griffith","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2013.11.011_bib18","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/sj.bmt.1705641","article-title":"Autoimmune hemolytic anemia following allogeneic hematopoietic stem cell transplantation in adult patients","volume":"39","author":"Sanz","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.11.011_bib19","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1046\/j.1537-2995.1999.39080824.x","article-title":"Delayed massive immune hemolysis mediated by minor ABO incompatibility after allogeneic peripheral blood progenitor cell transplantation","volume":"39","author":"Salmon","year":"1999","journal-title":"Transfusion"},{"key":"10.1016\/j.bbmt.2013.11.011_bib20","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/bjh.12210","article-title":"Incidence and natural history of pure red cell aplasia in major ABO-mismatched haematopoietic cell transplantation","volume":"160","author":"Aung","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2013.11.011_bib21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1365-2141.2004.05138.x","article-title":"Autoimmune haemolytic anaemia complicating haematopoietic cell transplantation in paediatric patients: high incidence and significant mortality in unrelated donor transplants for non-malignant diseases","volume":"127","author":"O'Brien","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2013.11.011_bib22","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1182\/blood-2007-10-118372","article-title":"A\u00a0review of transfusion practice before, during, and after hematopoietic progenitor cell transplantation","volume":"112","author":"Gajewski","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.11.011_bib23","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1034\/j.1399-0039.2003.00089.x","article-title":"Roles of HLA-B, HLA-C and HLA-DPA1 incompatibilities in the outcome of unrelated stem-cell transplantation","volume":"62","author":"Schaffer","year":"2003","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.bbmt.2013.11.011_bib24","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/01.TP.0000133513.29923.44","article-title":"Dose study of thymoglobulin during conditioning for unrelated donor allogeneic stem-cell transplantation","volume":"78","author":"Remberger","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2013.11.011_bib25","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/sj.bmt.1703811","article-title":"Low-intensity conditioning and hematopoietic stem cell transplantation in patients with renal and colon carcinoma","volume":"31","author":"Hentschke","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.11.011_bib26","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1600-0609.2011.01685.x","article-title":"Sirolimus and tacrolimus as immune prophylaxis compared to cyclosporine with or without methotrexate in patients undergoing allogeneic haematopoietic stem cell transplantation for non-malignant disorders","volume":"87","author":"Ringden","year":"2011","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.bbmt.2013.11.011_bib27","first-page":"619","article-title":"Similar incidence of graft-versus-host disease using HLA-A, -B and -DR identical unrelated bone marrow donors as with HLA-identical siblings","volume":"15","author":"Ringden","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.11.011_bib28","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1182\/blood-2002-03-0801","article-title":"Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care","volume":"100","author":"Svahn","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.11.011_bib29","article-title":"Risk factors for Epstein Barr virus related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation","volume":"98","author":"Uhlin","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2013.11.011_bib30","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1111\/j.1537-2995.2005.04157.x","article-title":"A\u00a0prospective randomized trial of a prophylactic platelet transfusion trigger of 10 x 10(9) per L versus 30 x 10(9) per L in allogeneic hematopoietic progenitor cell transplant recipients","volume":"45","author":"Diedrich","year":"2005","journal-title":"Transfusion"},{"key":"10.1016\/j.bbmt.2013.11.011_bib31","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1046\/j.1537-2995.2002.00209.x","article-title":"Severe immune hemolysis after minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation occurs more frequently after nonmyeloablative than myeloablative conditioning","volume":"42","author":"Worel","year":"2002","journal-title":"Transfusion"},{"key":"10.1016\/j.bbmt.2013.11.011_bib32","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1182\/blood-2003-08-2724","article-title":"Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients","volume":"105","author":"Slichter","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.11.011_bib33","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1537-2995.2005.04096.x","article-title":"Automated preparation of platelet concentrates from pooled buffy coats: in\u00a0vitro studies and experiences with the OrbiSac system","volume":"45","author":"Larsson","year":"2005","journal-title":"Transfusion"},{"key":"10.1016\/j.bbmt.2013.11.011_bib34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0955-3886(97)87108-1","article-title":"International forum: Europe. Buffy-coat-derived platelet concentrates: Swedish experience","volume":"18","author":"Hogman","year":"1997","journal-title":"Transfus Sci"},{"key":"10.1016\/j.bbmt.2013.11.011_bib35","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1537-2995.2009.02461.x","article-title":"Prolonged isolated red blood cell transfusion requirement after allogeneic blood stem cell transplantation: identification of patients at risk","volume":"50","author":"Dahl","year":"2010","journal-title":"Transfusion"},{"key":"10.1016\/j.bbmt.2013.11.011_bib36","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/j.1537-2995.2011.03069.x","article-title":"How do I approach ABO-incompatible hematopoietic progenitor cell transplantation?","volume":"51","author":"Daniel-Johnson","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.bbmt.2013.11.011_bib37","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jaut.2013.06.004","article-title":"Promotion and prevention of autoimmune disease by CD8+ T cells","volume":"45","author":"Gravano","year":"2013","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.bbmt.2013.11.011_bib38","first-page":"321","article-title":"A\u00a0role of herpes virus serology for the development of acute graft-versus-host disease. Leukaemia Working Party of the European Group for Bone Marrow Transplantation","volume":"5","author":"Bostrom","year":"1990","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.11.011_bib39","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/sj.bmt.1703686","article-title":"Clinically demonstrable anti-autoimmunity mediated by allogeneic immune cells favorably affects outcome after stem cell transplantation in human autoimmune diseases","volume":"30","author":"Hinterberger","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.11.011_bib40","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/MOH.0b013e3282e9a576","article-title":"Immune hemolysis following ABO-mismatched stem cell or solid organ transplantation","volume":"14","author":"Yazer","year":"2007","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.bbmt.2013.11.011_bib41","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1046\/j.1537-2995.1991.31191096190.x","article-title":"Red cell antibodies arising from solid organ transplants","volume":"31","author":"Ramsey","year":"1991","journal-title":"Transfusion"},{"key":"10.1016\/j.bbmt.2013.11.011_bib42","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1182\/blood.V79.11.3076.bloodjournal79113076","article-title":"Hemolysis of transfused group O red blood cells in minor ABO-incompatible unrelated-donor bone marrow transplants in patients receiving cyclosporine without posttransplant methotrexate","volume":"79","author":"Gajewski","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.11.011_bib43","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1182\/blood.V67.1.177.177","article-title":"Donor-derived red blood cell antibodies and immune hemolysis after allogeneic bone marrow transplantation","volume":"67","author":"Hows","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.11.011_bib44","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1046\/j.1365-2141.2001.02587.x","article-title":"Massive immune haemolysis after allogeneic peripheral blood stem cell transplantation with minor ABO incompatibility","volume":"112","author":"Bolan","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2013.11.011_bib45","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1097\/TP.0b013e3181f585c7","article-title":"Granulocyte colony-stimulating factor induced acute and chronic graft-versus-host disease","volume":"90","author":"Ringden","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2013.11.011_bib46","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nm.1948","article-title":"Induction of natural killer T cell-dependent alloreactivity by administration of granulocyte colony-stimulating factor after bone marrow transplantation","volume":"15","author":"Morris","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.bbmt.2013.11.011_bib47","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1089\/107999099313181","article-title":"Recombinant human granulocyte colony-stimulating factor (rHuG-CSF): effects on lymphocyte phenotype and function","volume":"19","author":"Rutella","year":"1999","journal-title":"J\u00a0Interferon Cytokine Res"},{"key":"10.1016\/j.bbmt.2013.11.011_bib48","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1182\/blood.V86.12.4422.bloodjournal86124422","article-title":"Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease","volume":"86","author":"Pan","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.11.011_bib49","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1182\/blood.V95.8.2484","article-title":"Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells","volume":"95","author":"Arpinati","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2013.11.011_bib50","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000337022","article-title":"Successful treatment of pure red cell aplasia with rituximab in patients after ABO-compatible allogeneic hematopoietic stem cell transplantation","volume":"5","author":"Jung","year":"2012","journal-title":"Case Rep Oncol"},{"key":"10.1016\/j.bbmt.2013.11.011_bib51","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/sj.bmt.1705031","article-title":"Pre-transplant reduction of isohaemagglutinin titres by donor group plasma infusion does not reduce the incidence of pure red cell aplasia in major ABO-mismatched transplants","volume":"36","author":"Damodar","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2013.11.011_bib52","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/sj.bmt.1704419","article-title":"Donor lymphocyte infusions for refractory pure red cell aplasia relapsing after both autologous and nonmyeloablative allogeneic peripheral stem cell transplantation","volume":"33","author":"Musso","year":"2004","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl","key":"10.1016\/j.bbmt.2013.11.011_bib53","first-page":"ECR33","article-title":"Successful treatment of pure red cell aplasia with repeated, low doses of rituximab in two patients after ABO-incompatible allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia","volume":"90","author":"Helbig","year":"2005","journal-title":"Haematologica"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879113005302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879113005302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:47:31Z","timestamp":1761058051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879113005302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S1083879113005302"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2013.11.011","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of Donor and Recipient ABO Incompatibility and Antibody-Associated Complications after Allogeneic Stem Cell Transplantation with Reduced-Intensity Conditioning","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2013.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}